APA (7th ed.) Citation

Huynh, W., Vucic, S., Menon, P., Rynders, A., Ho, K. S., Glanzman, R., & Hotchkin, M. T. (2021). Study protocol of RESCUE-ALS: A Phase 2, randomised, double-blind, placebo-controlled study in early symptomatic amyotrophic lateral sclerosis patients to assess bioenergetic catalysis with CNM-Au8 as a mechanism to slow disease progression. BMJ Publishing Group.

Chicago Style (17th ed.) Citation

Huynh, William, Steve Vucic, Parvathi Menon, Austin Rynders, Karen S. Ho, Robert Glanzman, and Michael T. Hotchkin. Study Protocol of RESCUE-ALS: A Phase 2, Randomised, Double-blind, Placebo-controlled Study in Early Symptomatic Amyotrophic Lateral Sclerosis Patients to Assess Bioenergetic Catalysis with CNM-Au8 as a Mechanism to Slow Disease Progression. BMJ Publishing Group, 2021.

MLA (8th ed.) Citation

Huynh, William, et al. Study Protocol of RESCUE-ALS: A Phase 2, Randomised, Double-blind, Placebo-controlled Study in Early Symptomatic Amyotrophic Lateral Sclerosis Patients to Assess Bioenergetic Catalysis with CNM-Au8 as a Mechanism to Slow Disease Progression. BMJ Publishing Group, 2021.